DrugDashboards

Theraflu Multi-Symptom Severe Cold

ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl · ACETAMINOPHEN 500 mg/237mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/237mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/237mL · Powder, For Solution · Oral · Haleon US Holdings LLC

NDC 00067-6426-06 · 6 PACKET in 1 CARTON / 237 mL in 1 PACKET · OTC MONOGRAPH DRUG · View full market →

The short version

6 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.9107 per unit over the past year.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Jun 2018Jun 2019$0.9107
7 price points · per · last surveyed Invalid DateSource: CMS NADAC

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for acetaminophen, dextromethorphan hbr, phenylephrine hcl (other) in the next 90 days

sole-source market · price up 3% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
M012
TE code
—
Approval date
—
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedJun 18, 2013
    Novartis Consumer Health — Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.

Manufacturers of ACETAMINOPHEN, DEXTROMETHORPHAN HBr, PHENYLEPHRINE HCl (Powder, For Solution)

LabelerStrengthFirst seenLast seen
Dolgencorp, LLCACETAMINOPHEN 500 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Haleon US Holdings LLCACETAMINOPHEN 650 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Procter & Gamble Manufactura S de RL de CVACETAMINOPHEN 500 mg/5g; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5g; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/5gAug 26, 2026Sep 2, 2026
Raritan Pharmaceuticals IncACETAMINOPHEN 500 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Wal-Mart Stores IncACETAMINOPHEN 500 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Walgreen Co.ACETAMINOPHEN 500 mg/1; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/1; PHENYLEPHRINE HYDROCHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Haleon US Holdings LLCACETAMINOPHEN 500 mg/237mL; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/237mL; PHENYLEPHRINE HYDROCHLORIDE 10 mg/237mLJul 15, 2026Aug 31, 2026
Procter & Gamble Manufactura S de RL de CVACETAMINOPHEN 500 mg/5g; PHENYLEPHRINE HYDROCHLORIDE 20 mg/5g; DEXTROMETHORPHAN HYDROBROMIDE 10 mg/5gJul 22, 2026Aug 19, 2026
Procter & Gamble Manufactura S de RL de CVACETAMINOPHEN 500 mg/5g; DEXTROMETHORPHAN HYDROBROMIDE 20 mg/5g; PHENYLEPHRINE HYDROCHLORIDE 10 mg/5gJul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Theraflu Multi-Symptom Severe Cold — NDC 00067-6426-06," retrieved September 3, 2026, https://drugdashboards.com/drug/00067642606.

Free to cite with attribution — see how the data is put together.